Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

RAMP up: Risk Adapted Post-Autologous Transplant Maintenance Therapy in MRD Positive Myeloma Patients

Karen Sweiss, Craig C. Hofmeister, Ghulam Rehman Mohyuddin, Amandeep Godara, Brian McClune, Damiano Rondelli, Danny Hadidi, David Chan, Matias Eugenio Sanchez, Min Hai, Mitch A. Phelps, Chukwuemeka Uzoka, Douglas Sborov

Blood (2023) 142 (Supplement 1): 4974.

https://doi.org/10.1182/blood-2023-191148

Published: 2023

Journal Articles

Relapsed and Refractory Multiple Myeloma with Pleural Involvement: A Case Series

Douglas Peters, Victoria A. Vardell, Gliceida Galarza Fortuna, Sterling Rosqvist, Charlotte B Wagner, Kelley Julian, Baylee Bryan, Mary Nicole Steinbach, Samuel Shewan, Lindsay Maxwell, Brian McClune, Amandeep Godara, Ghulam Rehman Mohyuddin, Matthew F Covington, Douglas Sborov

Blood (2023) 142 (Supplement 1): 6630.

https://doi.org/10.1182/blood-2023-179287

Published: 2023

Journal Articles

High Rates of Thrombotic Events in Newly Diagnosed Multiple Myeloma Patients Enrolled on the Maia Trial

Sterling Rosqvist, Victoria A. Vardell, Eric Anto, Gliceida Galarza Fortuna, Douglas Peters, Charlotte B Wagner, Baylee Bryan, Mary Nicole Steinbach, Samuel Shewan, Lindsay Maxwell, Michael R. Savona, Kelley Julian, Brian McClune, Ghulam Rehman Mohyuddin, Amandeep Godara, Muhamed Baljevic, Douglas Sborov

Blood (2023) 142 (Supplement 1): 4718.

https://doi.org/10.1182/blood-2023-190746

Published: 2023

Journal Articles

Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias

Charlotte B Wagner, Kelley Julian, Baylee Bryan, Mary Nicole Steinbach, Samuel Shewan, Lindsay Maxwell, Meghan Vigil, Ghulam Rehman Mohyuddin, Amandeep Godara, Brian McClune, Douglas Sborov

Blood (2023) 142 (Supplement 1): 6623.

https://doi.org/10.1182/blood-2023-174123

Published: 2023

Journal Articles

Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

Nirali N. Shah, Jacques Azzi, Brenda W Cooper, Abhinav Deol, John DiPersio, Divya Koura, Brian McClune, Lori S. Muffly, Muhammad Umair Mushtaq, Rupa Narayan, Hyung Chan Suh, Gregory Yanik, Sritama Nath, Jennifer Whangbo, Guenther Koehne

Blood (2023) 142 (Supplement 1): 4862.

https://doi.org/10.1182/blood-2023-180990

Published: 2023

Journal Articles

Time to Event Surrogate Endpoints in Multiple Myeloma Randomized Trials from 2005-2019: A Surrogacy Analysis

Tommy Etekal, Kelly Koehn, Douglas W. Sborov, Brian McClune, Vinay Prasad, Alyson Haslam, Katherine Berger, Christopher Booth, Samer Al Hadidi, Al-Ola Abdallah, Aaron M. Goodman, Ghulam Rehman Mohyuddin

Blood (2022) 140 (Supplement 1): 5047–5049.

https://doi.org/10.1182/blood-2022-163855

Published: 2022

Journal Articles

Multiple Myeloma Patients Treated at Academic Centers Have Improved Survival Outcomes

Victoria A. Vardell, Daniel A. Ermann, Srinivas K. Tantravahi, Brian McClune, Mary Nicole Steinbach, Ghulam Rehman Mohyuddin, Amandeep Godara, Douglas W. Sborov

Blood (2021) 138 (Supplement 1): 1971.

https://doi.org/10.1182/blood-2021-151899

Published: 2021

Journal Articles

Palliative Care Utilization, Transfusion Burden and Symptoms for Patients with Multiple Myeloma at the End of Life

Geoffrey McInturf, Kimberly Younger, Courtney Sanchez, Charles Walde, Al-Ola Abdallah, Leyla Shune, Nausheen Ahmed, Douglas W. Sborov, Amandeep Godara, Brian McClune, Christian Sinclair, Ghulam Rehman Mohyuddin

Blood (2021) 138 (Supplement 1): 4103.

https://doi.org/10.1182/blood-2021-153169

Published: 2021

Journal Articles

Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Hematological Malignancies: Insights from the National Inpatient Sample

Ghulam Rehman Mohyuddin, MD, Kellen Gil, Brian McClune, Nausheen Ahmed, Al-Ola Abdallah, MD, Siddhartha Ganguly, MD, Joseph P. McGuirk, DO, Leyla Shune, MD, Saqib Abbasi

Blood (2020) 136 (Supplement 1): 53–54.

https://doi.org/10.1182/blood-2020-142978

Published: 2020

Journal Articles

A Systematic Review and Network Meta-Analysis of Randomized Data on Efficacy of Novel Therapy Combinations in Patients with Lenalidomide Refractory Multiple Myeloma

Ghulam Rehman Mohyuddin, Jill Hampton, Muhammad Aziz, Sadik Khuder, PhD, Saad Ullah Malik, MD, Brian McClune, Al-Ola Abdallah, MD

Blood (2020) 136 (Supplement 1): 10–12.

https://doi.org/10.1182/blood-2020-142045

Published: 2020

Journal Articles

Hospitalization at the End of Life in Myeloma Patients: Lessons from the National Inpatient Sample

Saqib Abbasi, MD, Brian McClune, Al-Ola Abdallah, MD, Leyla Shune, MD, Ghulam Rehman Mohyuddin

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-142057

Published: 2020

Journal Articles

Inpatient Hospitalization's Associated Cost and Mortality for Myeloma Patients Undergoing Autologous Stem Cell Transplant: A 13-Year Analysis of the National Inpatient Sample

Saqib Abbasi, MD, Brian McClune, DO, Leyla Shune, MD, Suman Kambhampati, MD, Saqib Abbasi, MD

Blood (2019) 134 (Supplement_1): 3431.

https://doi.org/10.1182/blood-2019-131622

Published: 2019

Journal Articles

Conditioning Regimen Intensity May Affect Outcome in MDS Patients Undergoing Allogeneic Stem Cell Transplantation, Depending on MDS Subgroup

Barry S. Skikne, MD, Anurag K. Singh, MD, Sunil Abhyankar, MD, Tara L. Lin, MD, Leyla Shune, MD, Neil Dunavin, MD, Ajoy L. Dias, MD, Brian McClune, DO, Abdulraheem Yacoub, MD, Clint Divine, Haitham Abdelhakim, MD, Siddhartha Ganguly, MD, Jennifer Hanses, Carol E Webb, BA, Joseph P. McGuirk, DO

Blood (2019) 134 (Supplement_1): 5743.

https://doi.org/10.1182/blood-2019-130828

Published: 2019

Journal Articles

Maintenance and Consolidation Regimens after a Second Autologous Transplant for Multiple Myeloma: A Decade of Experiences

Ghulam Rehman Mohyuddin, MD, Maire Okoniewski, Osama Diab, MD, Siddhartha Ganguly, MD, Al-Ola Abdallah, MD, Leyla Shune, MD, Joseph P. McGuirk, DO, Brian McClune, DO

Blood (2019) 134 (Supplement_1): 5700.

https://doi.org/10.1182/blood-2019-130619

Published: 2019

Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD

Blood (2018) 132 (Supplement 1): 5760.

https://doi.org/10.1182/blood-2018-99-117654

Published: 2018

Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD

Blood (2018) 132 (Supplement 1): 5642.

https://doi.org/10.1182/blood-2018-99-117497

Published: 2018

Journal Articles

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Livia Hegerova, MD, Adam Bachan, Qing Cao, MS, Veronika Bachanova, MD PhD, Mark Reding, MD, John Rogosheske, PharmD, Brian McClune, DO, Aleksandr Lazaryan, MD PhD MPH, Greg M Vercellotti, MD FACP, Huong X Vu, PharmD

Blood (2017) 130 (Supplement 1): 3695.

https://doi.org/10.1182/blood.V130.Suppl_1.3695.3695

Published: 2017

Journal Articles

Comparison of Autologous Hematopoietic Cell Transplant (autoHCT), Bortezomib, Lenalidomide (Len) and Dexamethasone (RVD) Consolidation with Len Maintenance (ACM), Tandem Autohct with Len Maintenance (TAM) and Autohct with Len Maintenance (AM) for up-Front Treatment of Patients with Multiple Myeloma (MM): Primary Results from the Randomized Phase III Trial of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0702 - StaMINA Trial)

Blood (2016) 128 (22): LBA-1.

https://doi.org/10.1182/blood.V128.22.LBA-1.LBA-1

Published: 2016

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Elderly Patients: Prognosis Determined By Disease Risk Index

Fiona C. He, MD, Aleksandr Lazaryan, MD PhD MPH, Qing Cao, M.S., Claudio G Brunstein, MD, Shernan G. Holtan, MD, Erica D. Warlick, MD, Celalettin Ustun, MD, Brian McClune, DO, Mukta Arora, MD, Daniel J. Weisdorf, MD, Nelli Bejanyan, MD

Blood (2016) 128 (22): 2305.

https://doi.org/10.1182/blood.V128.22.2305.2305

Published: 2016

Journal Articles

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies

Yi-Bin Chen, MD, Jennifer Le-Rademacher, PhD, Deidre Marie Kiefer, MPH, Mehdi Hamadani, MD, John F. DiPersio, MD PhD, Mark R Litzow, MD, Michael Craig, MD, Mitchell E. Horwitz, MD, Andrew Artz, MD MS, Brian McClune, DO, Edmund K Waller, MD PhD, Hugo F. Fernandez, MD, Hien Kim Duong, MD, Hati Kobusingye, Mandi Proue, MPH, Rebecca J. Drexler, MPH, Mary M. Horowitz, MD MS, John P. Miller, MD PhD, Steven M. Devine, MD

Blood (2015) 126 (23): 389.

https://doi.org/10.1182/blood.V126.23.389.389

Published: 2015

NARROW

RAMP up: Risk Adapted Post-Autologous Transplant Maintenance Therapy in MRD Positive Myeloma Patients

Relapsed and Refractory Multiple Myeloma with Pleural Involvement: A Case Series

High Rates of Thrombotic Events in Newly Diagnosed Multiple Myeloma Patients Enrolled on the Maia Trial

Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias

Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

Time to Event Surrogate Endpoints in Multiple Myeloma Randomized Trials from 2005-2019: A Surrogacy Analysis

Multiple Myeloma Patients Treated at Academic Centers Have Improved Survival Outcomes

Palliative Care Utilization, Transfusion Burden and Symptoms for Patients with Multiple Myeloma at the End of Life

Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Hematological Malignancies: Insights from the National Inpatient Sample

A Systematic Review and Network Meta-Analysis of Randomized Data on Efficacy of Novel Therapy Combinations in Patients with Lenalidomide Refractory Multiple Myeloma

Hospitalization at the End of Life in Myeloma Patients: Lessons from the National Inpatient Sample

Inpatient Hospitalization's Associated Cost and Mortality for Myeloma Patients Undergoing Autologous Stem Cell Transplant: A 13-Year Analysis of the National Inpatient Sample

Conditioning Regimen Intensity May Affect Outcome in MDS Patients Undergoing Allogeneic Stem Cell Transplantation, Depending on MDS Subgroup

Maintenance and Consolidation Regimens after a Second Autologous Transplant for Multiple Myeloma: A Decade of Experiences

Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation

Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation for Elderly Patients: Prognosis Determined By Disease Risk Index

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only